Recent News

• 08.15.2025 - Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value
• 08.11.2025 - Heron Therapeutics Q2 2025 Conference Call
• 08.08.2025 - Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
• 08.08.2025 - Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress
• 08.08.2025 - Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress
• 08.08.2025 - Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
• 08.08.2025 - Heron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025

Recent Filings

• 08.15.2025 - EX-99.1 EX-99.1
• 08.15.2025 - 8-A12B Registration of securities [Section 12(b)]
• 08.15.2025 - 8-K Current report
• 08.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.12.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.12.2025 - 8-K Current report
• 08.12.2025 - 8-K Current report
• 08.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.08.2025 - 8-K Current report